LineaRx Secures New RNA Therapeutics Customers for Contract Research Services
Go back to LineaRx Secures New RNA Therapeutics Customers for Contract Research Services| Applied DNA Sciences, Inc. (NASDAQ: APDN) | Delayed: 5.62 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.62 | 52 Week High | $4.64 | |||
| Open | $5.62 | 52 Week Low | $2.15 | |||
| Day High | $5.62 | P/E | N/A | |||
| Day Low | $5.62 | EPS | $-0.01 | |||
| Volume | 55 | |||||
